Clinical Trial Update: Evaluation of the Prevalence of BP180 and BP230 Autoantibodies in the Serum of Patients With Pruritus Under Immunotherapy [NA]

View source ↗

Summary

A recruiting study evaluating how common BP180 and BP230 autoantibodies are in the serum of patients with chronic pruritus who have received immunotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pruritus

Snippet

Sponsor: University Hospital, Rouen | Conditions: Patients With Chronic Pruritus for More Than 1 Month Who Have Received Immunotherapy | NA | Status: RECRUITING